Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.

Dahl ES, Buj R, Leon KE, Newell JM, Imamura Y, Bitler BG, Snyder NW, Aird KM.

Mol Cancer Res. 2019 Aug;17(8):1710-1720. doi: 10.1158/1541-7786.MCR-18-1233. Epub 2019 May 20.

PMID:
31110157
2.

Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer.

Dahl ES, Aird KM.

Front Oncol. 2017 Nov 29;7:291. doi: 10.3389/fonc.2017.00291. eCollection 2017. Review.

Supplemental Content

Support Center